T1	Participants 99 121	breast cancer patients
T2	Participants 733 791	cancer patients receiving chemotherapy and/or radiotherapy
T3	Participants 890 980	fifty-eight breast cancer patients who received chemotherapy or radiotherapy were enrolled
